On 29 April 2026, the European Commission granted authorization for defatted rapeseed flour as a novel food under Regulation (EU) 2015/2283. This decision unlocks new formulation pathways for clean-label food manufacturers across Europe—particularly in baking and plant-based meat—by introducing a dual-function ingredient with high protein content and naturally occurring phenolic compounds. Its functional profile is driving cross-border procurement shifts, notably increasing demand for Chinese-sourced modified starches and natural antioxidants such as rosmarinic acid and ferulic acid.

Event Overview

On 29 April 2026, the European Commission officially approved defatted rapeseed flour (DRF) as a novel food for use in food products across the EU. The authorization permits its use as an ingredient in bakery products and meat analogues, up to specified maximum levels. The EFSA Panel on Nutrition, Novel Foods and Food Allergens confirmed DRF’s safety at intended use levels and noted its composition: ≥38% protein, ≥1.5% total phenolics (primarily sinapic acid derivatives), and low glucosinolate residue (<1.0 µmol/g). No post-market monitoring requirements were stipulated.

Industries Affected

Direct Trade Enterprises

Export-oriented trading firms handling agri-ingredients between China and the EU face immediate operational recalibration. Approval of DRF creates a new export category requiring compliance with EU novel food labeling, traceability, and batch documentation standards—notably Annex II reporting under Regulation (EU) No 2017/2470. For Chinese exporters, this means additional certification steps (e.g., health certificates referencing Commission Implementing Decision (EU) 2026/789) and potential delays in customs clearance if documentation lags behind market uptake.

Raw Material Procurement Enterprises

Purchasing departments at EU-based food developers are now evaluating DRF not as a standalone protein source, but as a functional matrix component. Its phenolic content introduces oxidative stability challenges during thermal processing—prompting concurrent sourcing of synergistic stabilizers. As a result, procurement teams are revising RFQs to bundle DRF with certified natural antioxidants (e.g., rosmarinic acid from Rosmarinus officinalis extracts) and compatibility-enhancing modified starches (e.g., hydroxypropylated or acetylated maize or tapioca starches), shifting from siloed to integrated ingredient specifications.

Food Processing Manufacturers

Bakery and plant-based meat producers must adapt formulations to accommodate DRF’s water absorption capacity (~180–220% of dry weight) and phenol-mediated Maillard inhibition. Pilot trials indicate that replacing 8–12% of wheat flour with DRF improves dough elasticity but reduces browning intensity—requiring adjustments in baking time/temperature and co-addition of reducing sugars or enzymatic browning promoters. Crucially, DRF’s native phenolics interact with iron in fortified systems, potentially accelerating lipid oxidation; thus, processors are testing antioxidant blends rather than single-component additions.

Supply Chain Service Providers

Logistics and regulatory consulting firms supporting ingredient imports into the EU are updating service offerings. Key developments include: (i) expanded novel food dossier review packages covering DRF-compatible co-ingredients; (ii) real-time alerts on national-level enforcement actions (e.g., Germany’s BVL sampling protocols for phenolic migration in baked goods); and (iii) warehousing solutions with climate-controlled zones for antioxidant-sensitive blends. These services are no longer niche—they are becoming baseline expectations for clients active in functional plant-protein innovation.

Key Considerations and Recommended Actions

Align technical specifications with EFSA’s compositional limits

Manufacturers sourcing DRF must verify supplier test reports against EFSA’s validated methods for sinapine and glucosinolate quantification (EFSA Journal 2025;23(4):e8921). Deviations—even within ±5%—may trigger re-evaluation under Article 11 of Regulation (EU) 2015/2283.

Validate antioxidant synergy before scale-up

Do not assume rosmarinic or ferulic acid will automatically stabilize DRF’s phenolics in final matrices. Conduct accelerated shelf-life testing (40°C/75% RH for 8 weeks) on prototype blends; observe for off-flavor development (e.g., bitter phenolic notes) and peroxide value shifts. Synergy is matrix-dependent—results from emulsion systems do not extrapolate to extruded plant meats.

Update labeling workflows for combined ingredient claims

When marketing products containing both DRF and added natural antioxidants, avoid implying additive functional effects (e.g., “enhanced antioxidant protection”) unless substantiated by EFSA-approved health claims. Instead, use compliant phrasing: “Contains defatted rapeseed flour and rosmarinic acid, both contributing to the product’s natural antioxidant profile.”

Monitor national-level implementation timelines

Although EU-wide authorization is effective, Member States retain discretion on transitional arrangements. France and the Netherlands have announced phased enforcement (starting Q3 2026); Poland and Hungary have yet to publish guidance. Procurement teams should track national food authority bulletins weekly—not just EC notices.

Editorial Perspective / Industry Observation

Analysis shows this approval marks a structural pivot—not just a new ingredient entry. DRF’s dual functionality (protein + endogenous antioxidant) challenges the long-standing industry practice of treating structure-modifying and preservation ingredients as separate procurement categories. Observably, the ripple effect is accelerating integration across Chinese ingredient supply chains: starch modifiers are now being co-developed with antioxidant suppliers under joint application testing programs. From an industry perspective, this reflects a broader shift toward “functionally bundled” novel food inputs—where regulatory approval acts as a catalyst for upstream technical convergence. Current more relevant interpretation is that DRF functions less as a replacement ingredient and more as a system integrator—its value lies in enabling tighter coupling between texture, nutrition, and shelf-life design parameters.

Conclusion

This authorization does not merely expand the EU’s novel food catalog—it reshapes formulation logic for clean-label food development. Rather than signaling isolated opportunity for individual ingredient suppliers, it underscores a deeper trend: regulatory milestones increasingly serve as synchronization points for multi-component innovation. A rational observation is that competitive advantage will accrue less to firms offering single high-performing ingredients, and more to those delivering pre-validated, functionally coherent ingredient systems—with documented compatibility, regulatory alignment, and application-specific performance data.

Source Attribution

European Commission Implementing Decision (EU) 2026/789 of 29 April 2026 authorising the placing on the market of defatted rapeseed flour as a novel food under Regulation (EU) 2015/2283 (OJ L 115, 30.4.2026, p. 1). EFSA Scientific Opinion on the safety of defatted rapeseed flour (EFSA Journal 2025;23(4):e8921). Note: National enforcement timelines, analytical method harmonization status, and commercial availability of certified DRF batches remain subject to ongoing verification and are recommended for continuous monitoring through EFSA’s Novel Food Catalogue updates and EU RASFF notifications.